Chief Research Officer at US Fertility, Kate Devine, M.D., receives prestigious award from ASRM
Presented at the 79th ASRM Scientific Congress & Expo, US Fertility’s Dr. Devine is recognized for her excellence in research by receiving the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.
LOS ANGELES [October 20, 2023] – US Fertility celebrates, Kate Devine, M.D., Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.
“I am incredibly humbled to receive such an honor and send gratitude to ASRM and my physician peers who have supported me,” shares Dr. Devine. “As a physician-scientist, it is a privilege to serve my patients by providing evidence-based fertility care and continually investigating best practices to help them meet their family-building goals.”
The New Investigator Award is a highly competitive award that recognizes meritorious research conducted by an individual who is within 10 years of the completion of academic and professional training. The award was announced during ASRM’s Opening Ceremony on Monday, October 16, 2023 and presented during the ASRM Research Symposium on Wednesday, October 18, 2023.
“[Dr. Devine] has displayed a consistent and highly successful track record as a clinician-scientist performing and publishing important Randomized Clinical Trials that have had significant impact on the practice of REI [reproductive endocrinology],” shares Michael A. Thomas, M.D., ASRM President.
“Dr. Devine defines the combination of clinician and researcher who devotes themselves to research to carry the field of reproductive medicine forward, allowing us to provide better care for our patients, and make a difference in the lives of so many,” shared Joseph Doyle, M.D., SGF physician, and Robert J. Stillman, M.D., SGF Medical Director Emeritus, in a letter of support for the award.
Dr. Devine is a board-certified reproductive endocrinologist who sees patients at SGF’s Washington, D.C., K Street location. She serves as Associate Program Director to fellows at the National Institutes of Health (NIH) who are training to become reproductive endocrinologists and to residents training to become obstetricians/gynecologists at Georgetown School of Medicine and GW School of Medicine, where she serves as Clinical Professor. Dr. Devine also serves as the Medical Director and Chief Research Officer at US Fertility, Chair of the Society for Reproductive Endocrinology and Infertility (SREI) Research Committee, and Chair of the Society for Assisted Reproductive Technology (SART) Quality Assurance Committee.
Learn more about US Fertility’s Research Division, which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.
ABOUT US FERTILITY
US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, along with Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. To date, US Fertility and Ovation Fertility practices have helped more than 225,000 individuals and couples build their families using assisted reproductive technology. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and by providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. Together with a growing suite of life science services, US Fertility is expanding access to the highest quality reproductive health care across over 100 clinic locations and 32 IVF laboratories. https://www.usfertility.com